Novel strains of mice deficient for the vesicular acetylcholine transporter: Insights on transcriptional regulation and control of locomotor behavior

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Martins Silva, Cristina ^a,d   de Jaeger, Xavier ^a,b   Guzman, Monica S ^a   Lima, Ricardo D F ^b   Santos, Magda S ^b,e   Kushmerick, Christopher ^b   Gomez, Marcus V ^b   Caron, Marc G ^c   Prado, Marco A M ^a   Prado, Vania F ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; VESICULAR ACETYLCHOLINE TRANSPORTER; MESSENGER RNA; SLC18A3 PROTEIN, MOUSE;

ACETYLCHOLINE RELEASE; ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CELL POPULATION; CHOLINERGIC ACTIVITY; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DNA MODIFICATION; GENE CASSETTE; GENE EXPRESSION; GENE LOCATION; INTRON; LOCOMOTION; LOXP SITE; MOTOR CONTROL; MOUSE; MOUSE MUTANT; MOUSE STRAIN; MUTANT; NERVE CELL; NEUROMUSCULAR FUNCTION; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC TRANSCRIPTION; GENETICS; HABITUATION; HYPERKINESIA; METABOLISM; MOTOR ACTIVITY; NEUROMUSCULAR SYNAPSE; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY;

ANIMALIA; MUS;

ACETYLCHOLINE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; GENE EXPRESSION REGULATION; GENETIC LOCI; HABITUATION, PSYCHOPHYSIOLOGIC; HYPERKINESIS; MICE; MICE, MUTANT STRAINS; MOTOR ACTIVITY; MUTAGENESIS, INSERTIONAL; NEUROMUSCULAR JUNCTION; PHENOTYPE; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 79952494278     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017611     Document Type: Article

References (60)

1. Everitt BJ, Robbins TW, (1997) Central cholinergic systems and cognition. Annu Rev Psychol 48: 649-684.
2. Wess J, Eglen RM, Gautam D, (2007) Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 6: 721-733.
3. Taly A, Corringer PJ, Guedin D, Lestage P, Changeux JP, (2009) Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov 8: 733-750.
4. Scarr E, (2009) Muscarinic receptors in psychiatric disorders- can we mimic 'health'? Neurosignals 17: 298-310.
5. Wess J, Duttaroy A, Gomeza J, Zhang W, Yamada M, et al. (2003) Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarinic receptor knockout mice: a review. Life Sci 72: 2047-2054.
6. Grutter T, de Carvalho LP, Dufresne V, Taly A, Edelstein SJ, et al. (2005) Molecular tuning of fast gating in pentameric ligand-gated ion channels. Proc Natl Acad Sci U S A 102: 18207-18212.
7. Weisman D, Hakimian E, Ho GJ, (2006) Interleukins, inflammation, and mechanisms of Alzheimer's disease. Vitam Horm 74: 505-530.
8. Griffin WS, (2006) Inflammation and neurodegenerative diseases. Am J Clin Nutr 83: 470S-474S.
9. Wilms H, Zecca L, Rosenstiel P, Sievers J, Deuschl G, et al. (2007) Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr Pharm Des 13: 1925-1928.
10. Misgeld T, Burgess RW, Lewis RM, Cunningham JM, Lichtman JW, et al. (2002) Roles of neurotransmitter in synapse formation: development of neuromuscular junctions lacking choline acetyltransferase. Neuron 36: 635-648.
11. Brandon EP, Lin W, D'Amour KA, Pizzo DP, Dominguez B, et al. (2003) Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice. J Neurosci 23: 539-549.
12. de Castro BM, De Jaeger X, Martins-Silva C, Lima RD, Amaral E, et al. (2009) The vesicular acetylcholine transporter is required for neuromuscular development and function. Mol Cell Biol 29: 5238-5250.
13. Prado VF, Martins-Silva C, de Castro BM, Lima RF, Barros DM, et al. (2006) Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 51: 601-612.
14. Lima RF, Prado VF, Prado MA, Kushmerick C, (2010) Quantal release of acetylcholine in mice with reduced levels of the vesicular acetylcholine transporter. J Neurochem 113: 943-951.
15. Lara A, Damasceno DD, Pires R, Gros R, Gomes ER, et al. (2010) Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure. Mol Cell Biol 30: 1746-1756.
16. Guidine PA, Rezende GH, Queiroz CM, Mello LE, Prado VF, et al. (2008) Vesicular acetylcholine transporter knock-down mice are more susceptible to pilocarpine induced status epilepticus. Neurosci Lett 436: 201-204.
17. de Castro BM, Pereira GS, Magalhaes V, Rossato JI, De Jaeger X, et al. (2009) Reduced expression of the vesicular acetylcholine transporter causes learning deficits in mice. Genes Brain Behav 8: 23-35.
18. Eiden LE, (1998) The cholinergic gene locus. J Neurochem 70: 2227-2240.
19. Naciff JM, Behbehani MM, Misawa H, Dedman JR, (1999) Identification and transgenic analysis of a murine promoter that targets cholinergic neuron expression. J Neurochem 72: 17-28.
20. Misawa H, Nakata K, Toda K, Matsuura J, Oda Y, et al. (2003) VAChT-Cre. Fast and VAChT-Cre.Slow: postnatal expression of Cre recombinase in somatomotor neurons with different onset. Genesis 37: 44-50.
21. Schutz B, Chen L, Schafer MK, Weihe E, Eiden LE, (2000) Somatomotor neuron-specific expression of the human cholinergic gene locus in transgenic mice. Neuroscience 96: 707-722.
22. Schutz B, Damadzic R, Weihe E, Eiden LE, (2003) Identification of a region from the human cholinergic gene locus that targets expression of the vesicular acetylcholine transporter to a subset of neurons in the medial habenular nucleus in transgenic mice. J Neurochem 87: 1174-1183.
23. Harper DG, Stopa EG, McKee AC, Satlin A, Fish D, et al. (2004) Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease. Neurobiol Aging 25: 771-781.
24. Harper DG, Volicer L, Stopa EG, McKee AC, Nitta M, et al. (2005) Disturbance of endogenous circadian rhythm in aging and Alzheimer disease. Am J Geriatr Psychiatry 13: 359-368.
25. Gil-Bea FJ, Aisa B, Schliebs R, Ramirez MJ, (2007) Increase of locomotor activity underlying the behavioral disinhibition in tg2576 mice. Behav Neurosci 121: 340-344.
26. Balla A, Koneru R, Smiley J, Sershen H, Javitt DC, (2001) Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release. Neuropsychopharmacology 25: 157-164.
27. Mattsson A, Lindqvist E, Ogren SO, Olson L, (2005) Increased phencyclidine-induced hyperactivity following cortical cholinergic denervation. Neuroreport 16: 1815-1819.
28. Mehler-Wex C, Riederer P, Gerlach M, (2006) Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox Res 10: 167-179.
29. Granon S, Changeux JP, (2006) Attention-deficit/hyperactivity disorder: a plausible mouse model? Acta Paediatr 95: 645-649.
30. Gerber DJ, Sotnikova TD, Gainetdinov RR, Huang SY, Caron MG, et al. (2001) Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci U S A 98: 15312-15317.
31. Miyakawa T, Yamada M, Duttaroy A, Wess J, (2001) Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 21: 5239-5250.
32. Molinengo L, Fundaro A, Orsetti M, (1989) The effect of chronic atropine administration on mouse motility and on ACh levels in the central nervous system. Pharmacol Biochem.Behav 32: 1075-1077.
33. Shannon HE, Peters SC, (1990) A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice. J Pharmacol Exp Ther 255: 549-553.
34. Bymaster FP, Heath I, Hendrix JC, Shannon HE, (1993) Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. J Pharmacol Exp Ther 267: 16-24.
35. Ukai M, Kobayashi T, Kameyama T, (1994) Characterization of the effects of scopolamine on the habituation of exploratory activity: differential effects of oxotremorine and physostigmine. Gen Pharmacol 25: 433-438.
36. Granon S, Faure P, Changeux JP, (2003) Executive and social behaviors under nicotinic receptor regulation. Proc Natl Acad Sci U S A 100: 9596-9601.
37. Maubourguet N, Lesne A, Changeux JP, Maskos U, Faure P, (2008) Behavioral sequence analysis reveals a novel role for beta2* nicotinic receptors in exploration. PLoS Comput Biol 4: e1000229.
38. Crawley JN, (1999) Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 835: 18-26.
39. Rajewsky K, Gu H, Kuhn R, Betz UA, Muller W, et al. (1996) Conditional gene targeting. J Clin Invest 98: 600-603.
40. Alfonso A, Grundahl K, McManus JR, Asbury JM, Rand JB, (1994) Alternative splicing leads to two cholinergic proteins in Caenorhabditis elegans. J Mol Biol 241: 627-630.
41. Alfonso A, Grundahl K, McManus JR, Rand JB, (1994) Cloning and characterization of the choline acetyltransferase structural gene (cha-1) from C. elegans. J Neurosci 14: 2290-2300.
42. Kitamoto T, Wang W, Salvaterra PM, (1998) Structure and organization of the Drosophila cholinergic locus. J Biol Chem 273: 2706-2713.
43. Erickson JD, Varoqui H, Schafer MK, Modi W, Diebler MF, et al. (1994) Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J Biol Chem 269: 21929-21932.
44. Cervini R, Houhou L, Pradat PF, Bejanin S, Mallet J, et al. (1995) Specific vesicular acetylcholine transporter promoters lie within the first intron of the rat choline acetyltransferase gene. J Biol Chem 270: 24654-24657.
45. Kitamoto T, Ikeda K, Salvaterra PM, (1995) Regulation of choline acetyltransferase/lacZ fusion gene expression in putative cholinergic neurons of Drosophila melanogaster. J Neurobiol 28: 70-81.
46. Salvaterra PM, Kitamoto T, Ikeda K, (1993) Molecular genetic specification of cholinergic neurons. Prog Brain Res 98: 167-173.
47. Yasuyama K, Kitamoto T, Salvaterra PM, (1995) Localization of choline acetyltransferase-expressing neurons in the larval visual system of Drosophila melanogaster. Cell Tissue Res 282: 193-202.
48. Lee MH, Salvaterra PM, (2002) Abnormal chemosensory jump 6 is a positive transcriptional regulator of the cholinergic gene locus in Drosophila olfactory neurons. J Neurosci 22: 5291-5299.
49. Lonnerberg P, Lendahl U, Funakoshi H, rhlund-Richter L, Persson H, et al. (1995) Regulatory region in choline acetyltransferase gene directs developmental and tissue-specific expression in transgenic mice. Proc Natl Acad Sci U S A 92: 4046-4050.
50. Lonnerberg P, Schoenherr CJ, Anderson DJ, Ibanez CF, (1996) Cell type-specific regulation of choline acetyltransferase gene expression. Role of the neuron-restrictive silencer element and cholinergic-specific enhancer sequences. J Biol Chem 271: 33358-33365.
51. Di CG, Morelli M, Consolo S, (1994) Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci 17: 228-233.
52. Gomeza J, Zhang L, Kostenis E, Felder CC, Bymaster FP, et al. (2001) Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice. Life Sci 68: 2457-2466.
53. Reavill C, Stolerman IP, (1990) Locomotor activity in rats after administration of nicotinic agonists intracerebrally. Br J Pharmacol 99: 273-278.
54. Museo E, Wise RA, (1990) Microinjections of a nicotinic agonist into dopamine terminal fields: effects on locomotion. Pharmacol Biochem Behav 37: 113-116.
55. Museo E, Wise RA, (1990) Locomotion induced by ventral tegmental microinjections of a nicotinic agonist. Pharmacol Biochem Behav 35: 735-737.
56. Panagis G, Nisell M, Nomikos GG, Chergui K, Svensson TH, (1996) Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat. Brain Res 730: 133-142.
57. Sango K, McDonald MP, Crawley JN, Mack ML, Tifft CJ, et al. (1996) Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat Genet 14: 348-352.
58. Neumann M, Wang Y, Kim S, Hong SM, Jeng L, et al. (2009) Assessing gait impairment following experimental traumatic brain injury in mice. J Neurosci Methods 176: 34-44.
59. Vianna MR, Izquierdo LA, Barros DM, de Souza MM, Rodrigues C,et al. Pharmacological differences between memory consolidation of habituation to an open field and inhibitory avoidance learning. Braz J Med Biol Res 34: 233-240.
60. Gainetdinov RR, Bohn LM, Sotnikova TD, Cyr M, Laakso A, et al. (2003) Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron 38: 291-303.